Carcinogenesis, Vol. 21, No. 7, 1391-1396,
July 2000
© 2000 Oxford University Press
Carcinogenesis |
Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis
1 Experimental Pathology and Chemotherapy Division,
2 Section for Studies on Metastasis,
3 Oncogene Division and
4 Director, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045,
5 Department of Urology, Institute of Clinical Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba City, Ibaraki 305-8575, and
6 Department of Urology, Tokyo Metropolitan Komagome Hospital, 3-18-22 Hon-Komagome, Bunkyo-ku, Tokyo 113-8677, Japan
We have established a transgenic rat line carrying three copies of the human c-Ha-ras proto-oncogene with its own original promoter region, Jcl/SD-TgN(HrasGen)128Ncc (Hras128) rat. c-Ha-ras protein from expression of transduced and endogenous c-Ha-ras genes could be detected in the bladder epithelium of untreated transgenic rats. To examine their susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced urinary bladder carcinogenesis, male transgenic and wild-type littermates were treated with 0.05% BBN in their drinking water for 10 weeks and then killed at week 20. The numbers and volumes of total macroscopic bladder tumors including both transitional cell papillomas and carcinomas (TCC) per rat were much greater in Hras128 rats than in their wild-type counterparts. The numbers of carcinomas per rat were also significantly greater in Hras128 rats. Two cases of TCC exhibiting invasion of the bladder muscle layer, which is extremely rare in the wild-type animals under the experimental conditions used, were also observed in Hras128 rats. The GGC
GAC mutations at codon 12 of the transgene were observed in only two TCC out of 21 bladder tumors (9.5%), assessed by RFLP analysis and direct sequencing. SSCP analysis did not show any endogenous c-Ha-ras gene mutations. One of 25 tumors (4.0%) in wild-type rats had an endogenous c-Ha-ras gene mutation at codon 12 that was detected (GGAGAA) by single-strand conformation polymorphism and direct sequencing. These results indicate that the Hras128 rat is highly susceptible to BBN carcinogenesis and may be utilized as a rat model for analysis of bladder tumor development. The mutation findings indicate that the enhanced tumor development is not primarily due to mutations occurring in the transgene.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Zhou, Y. Jiang, A. Tan, A. R. Greenlee, Y. Shen, L. Liu, and Q. Yang Silencing of N-Ras Gene Expression Using shRNA Decreases Transformation Efficiency and Tumor Growth in Transformed Cells Induced by Anti-BPDE Toxicol. Sci., October 1, 2008; 105(2): 286 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohnishi, K. Fukamachi, Y. Ohshima, X. Jiegou, S. Ueda, M. Iigo, N. Takasuka, A. Naito, K.-i. Fujita, Y. Matsuoka, et al. Possible Application of Human c-Ha-ras Proto-Oncogene Transgenic Rats in a Medium-Term Bioassay Model for Carcinogens Toxicol Pathol, April 1, 2007; 35(3): 436 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Morimura, J. S. Kang, M. Wei, H. Wanibuchi, H. Tsuda, and S. Fukushima Lack of Urinary Bladder Carcinogenicity of Sodium L-Ascorbate in Human c-Ha-ras Proto-Oncogene Transgenic Rats Toxicol Pathol, December 1, 2005; 33(7): 766 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vecchione, C. Sevignani, E. Giarnieri, N. Zanesi, H. Ishii, R. Cesari, L. Y. Y. Fong, L. G. Gomella, C. M. Croce, and R. Baffa Inactivation of the FHIT Gene Favors Bladder Cancer Development Clin. Cancer Res., November 15, 2004; 10(22): 7607 - 7612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Diaz, L. Lopez-Barcons, D. Ahn, A. Garcia-Espana, A. Yoon, J. Matthews, R. Mangues, R. Perez-Soler, and A. Pellicer Complex effects of Ras proto-oncogenes in tumorigenesis Carcinogenesis, April 1, 2004; 25(4): 535 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsuoka, K. Fukamachi, T. Hamaguchi, H. Toriyama-Baba, H. Kawaguchi, M. Kusunoki, H. Yoshida, and H. Tsuda Rapid Emergence of Mammary Preneoplastic and Malignant Lesions in Human c-Ha-ras Proto-Oncogene Transgenic Rats: Possible Application for Screening of Chemopreventive Agents Toxicol Pathol, October 1, 2003; 31(6): 632 - 637. [Abstract] [PDF]
|
|
|
|
|
|
B. S. Han, K. Fukamachi, N. Takasuka, T. Ohnishi, M. Maeda, T. Yamasaki, and H. Tsuda Inhibitory effects of 17{beta}-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats Carcinogenesis, July 1, 2002; 23(7): 1209 - 1215. [Abstract] [Full Text] [PDF]
|
|